| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NanoString Technologies Inc | Chief Commercial Officer | Restricted Stock Units | 0 | $438K | $2.19 | May 6, 2024 | Direct |
| Cytek Biosciences, Inc. | Chief Commercial Officer | Restricted Stock Units | 39.6K | $237K | $5.98 | Aug 18, 2023 | Direct |
| Cytek Biosciences, Inc. | Chief Commercial Officer | Common Stock | 8.76K | $83.2K | $9.50 | Aug 18, 2023 | Direct |
| NanoString Technologies Inc | Chief Commercial Officer | Common Stock | 200K | May 6, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NSTG | NanoString Technologies Inc | May 6, 2024 | 2 | $0 | 4 | May 8, 2024 | Chief Commercial Officer |
| NSTG | NanoString Technologies Inc | Aug 28, 2023 | 1 | $0 | 4 | Aug 28, 2023 | Chief Commercial Officer |
| NSTG | NanoString Technologies Inc | Aug 28, 2023 | 0 | $0 | 3 | Aug 28, 2023 | Chief Commercial Officer |
| CTKB | Cytek Biosciences, Inc. | Aug 18, 2023 | 6 | -$15.5K | 4 | Aug 21, 2023 | Chief Commercial Officer |
| CTKB | Cytek Biosciences, Inc. | May 18, 2023 | 6 | -$25.1K | 4 | May 19, 2023 | Chief Commercial Officer |
| CTKB | Cytek Biosciences, Inc. | Mar 3, 2023 | 2 | $0 | 4 | Mar 7, 2023 | Chief Commercial Officer |
| CTKB | Cytek Biosciences, Inc. | Apr 25, 2022 | 2 | $0 | 4 | Apr 27, 2022 | Chief Commercial Officer |
| CTKB | Cytek Biosciences, Inc. | Apr 25, 2022 | 0 | $0 | 3 | Apr 27, 2022 | Chief Commercial Officer |